Microfluidic Device Type Improves Heart mRNA Delivery <i>In Vivo</i>

To improve lipid nanoparticle (LNP)-mediated delivery to nonliver tissues, scientists modify LNP chemistry or add targeting ligands. One underexplored alternative is to change the formulation process that creates the LNP. Here, we report that an LNP formulated with a herringbone mixer led to 2-fold more heart delivery than the same LNP formulated with a bifurcating mixer. The two LNPs had similar biophysical traits, yet they adsorbed different protein coronas, suggesting that the effect was driven by systemic physiology. By using spatial transcriptomics to track LNP delivery in a mouse model of atherosclerosis, we found that the improved LNP delivered mRNA to diseased regions and cardiomyocytes after an intravenous injection. These data suggest that it is possible to increase heart delivery <i>via</i> nanoparticle processing.

Authors

Institutions

Publication Details

Journal
Langmuir
Published
2025-10-02
DOI
https://doi.org/10.1021/acs.langmuir.5c02612
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Microfluidic Device Type Improves Heart mRNA Delivery In Vivo

Kyung In Baek, Leandro Choi, Philip J. Santangelo, Bora Jang et al.
Langmuir
RNA Interference and Gene Delivery
article

Microfluidic Device Type Improves Heart mRNA Delivery In Vivo

Kyung In Baek, Leandro Choi, Philip J. Santangelo, Bora Jang, Hanjoong Jo, Dong Won Kang, James E. Dahlman, Christian Park, Elisa Schrader Echeverri, Ruei-Chun Hung, Ananda R. Podilapu, Karen E. Tiegreen, Hyejin Kim, Hannah E. Peck, Avraham Shakked, Kiyoung Jeong
article en

Abstract

To improve lipid nanoparticle (LNP)-mediated delivery to nonliver tissues, scientists modify LNP chemistry or add targeting ligands. One underexplored alternative is to change the formulation process that creates the LNP. Here, we report that an LNP formulated with a herringbone mixer led to 2-fold more heart delivery than the same LNP formulated with a bifurcating mixer. The two LNPs had similar biophysical traits, yet they adsorbed different protein coronas, suggesting that the effect was driven by systemic physiology. By using spatial transcriptomics to track LNP delivery in a mouse model of atherosclerosis, we found that the improved LNP delivered mRNA to diseased regions and cardiomyocytes after an intravenous injection. These data suggest that it is possible to increase heart delivery <i>via</i> nanoparticle processing.

LangmuirVol. 41(40)
Georgia Institute of Technology (US), Emory University (US), The Wallace H. Coulter Department of Biomedical Engineering (US)
Openalex Percentile: Top 76%
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Microfluidic Device Type Improves Heart mRNA Delivery <i>In Vivo</i> — Kyung In Baek, Leandro Choi, et al. · Langmuir (2025) | TGRS Research Map | TGRS